hero section gradient
15 handpicked stocks

Best Places to Work Index

This carefully curated collection features companies celebrated for creating exceptional workplace environments. Our professional analysts have selected businesses where happy employees drive innovation and growth, potentially leading to stronger returns for investors.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Market cap breakdown for the 'Best Places to Work Index' basket, highlighting concentration and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance tends to lower volatility, offering more stability and closer tracking to broad-market movements.
  • Suitable as a core, long-term holding to anchor diversified portfolios rather than a speculative allocation.
  • Expect steady, long-term value appreciation; not designed for rapid, short-term explosive gains.
Total Market Cap
  • WDAY: $65.59B

  • PAYC: $11.64B

  • NSP: $1.80B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Companies with outstanding workplace cultures tend to have lower employee turnover and higher productivity. These businesses often attract top talent, foster innovation, and build sustainable competitive advantages that can translate to long-term financial success.

2

What You Need to Know

This collection includes companies from various sectors that consistently rank high on prestigious "Best Places to Work" lists from Fortune and Glassdoor. The focus is on businesses with proven track records of employee satisfaction and strong human capital management.

3

Why These Stocks

Each company was selected because it either creates exceptional workplace environments or provides the tools and services that help other businesses do so. In today's competitive labor market, these companies are well-positioned to attract and retain top talent.

Why You'll Want to Watch These Stocks

🏆

Award-Winning Culture Matters

Companies recognized for exceptional workplaces often outperform their competitors. When employees are happy, productivity soars and innovations flourish.

🧲

Talent Magnets Win Big

In today's competitive job market, companies that attract and retain top talent have a significant edge. These stocks represent businesses that excel at becoming employers of choice.

📊

Data-Backed Selection Process

Each company in this collection has earned its place by consistently ranking high on prestigious "Best Places to Work" lists, providing an objective measure of workplace quality.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions